Proof of Concept

During the last ten years, HemoShear’s technology has been validated in 15 peer-reviewed publications. The technology has reliably and accurately replicated human response in over 3000 experiments and using over 800 human donors. Extensive proof-of-concept studies have been conducted with the HemoShear technology to validate that the technology is able to reliably and consistently replicate human (and animal) in-vivo conditions:

Parameters Peer-Reviewed Publications
Vascular Cell Biology
Artery Structure
Endothelial Cell Function
Smooth Muscle Cell Function
Regional Hemodynamics Differentially Regulate Cell Phenotypes
Disease-Prone Hemodynamic Flow Creates Athero-Prone Cell Phenotype
Inflammation & Inflammatory Response
Extracellular Matrix, Fibronectin Biology
Novel Interleukin-8 Biology
Endothelial Barrier Function
ER Stress Biology in Atherosclerosis
Endothelial Capillary Sprouting
Gelfand et al., J Magn Reson Imaging, 2006
Simmers, et al., AJP Heart Circ Phys, 2007
Orr et al., J Cell Biol, 2007
Hastings, et al., AJP Cell Phys, 2007
Anderson, et al., Am J Path, 2008
Harry et al., ATVB, 2008
Feaver, et al., ATVB, 2008
Thomas et al., Am J Physiol Heart Circ Physiol, 2009
Jin et al., J Muscle Res Cell Motil, 2009
Hastings, et al., ATVB, 2009
Feaver, et al., Circ Res, 2010


 

Studies that have been performed to validate the effects of drugs in the HemoShear technology correlate with published clinical evidence, including:


 

These studies confirm that HemoShear’s technology can reliably and consistently produce results which robustly represent the in-vivo biological response of animal or humans cells.